Global Epidemiology, Prevention, and Management of Hepatocellular Carcinoma
The DOI matches its Crossref record; 159 of the 159 references it cites were found in a registry or an index.
Abstract
The incidence rate of hepatocellular carcinoma (HCC) is rising. It is one of the most common cancers worldwide and accounts for substantial morbidity and mortality. Chronic hepatitis B virus (HBV) infection, chronic hepatitis C virus (HCV) infection, and nonalcoholic fatty liver disease (NAFLD) are the most important etiologies of HCC, and effective screening and management strategies are crucial to reduce the HCC risk. For HBV, which accounts for the majority of HCC cases, most infections were acquired via perinatal and early horizontal transmission. Universal vaccination of newborns has led to a decline in HCC incidence compared with the pre-vaccination era. Effective antiviral therapies with nucleos(t)ide analogues or pegylated interferon reduced the incidence of HCC. For HCV, the emergence of effective direct-acting antiviral (DAA) agents has substantially improved cure rates; therefore all patients with HCV should be considered for DAA treatment. The most important obstacle in eliminating HCV is access to therapy. For NAFLD, the global incidence is increasing rapidly, thus its impact on HCC incidence may be explosive. Progression to HCC in NAFLD happens particularly in those with nonalcoholic steatohepatitis (NASH) and exacerbated by metabolic syndrome, or PNPLA3 gene polymorphism. Lifestyle changes are imperative while drug therapy has yet to demonstrate substantive protective effects on HCC prevention. For management of HCC, early diagnosis via imaging surveillance among persons with HCC risk factors remains the most important strategy to identify early-stage disease appropriate for resection or transplantation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alberti, K. G. M. M., Eckel, R. H., Grundy, S. M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., Fruchart, J.-C., James, W. P. T., Loria, C. M., & Smith, S. C. (2009) · Circulation · doi:10.1161/circulationaha.109.192644 · Cited by 14,860
Lozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., Abraham, J., Adair, T., Aggarwal, R., Ahn, S. Y., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61728-0 · Cited by 14,070
Sorafenib in advanced hepatocellular carcinoma
Llovet, J. M., Ricci, S., Mazzaferro, V., Hilgard, P., Gane, E., Blanc, J.-F., de Oliveira, A. C., Santoro, A., Raoul, J.-L., Forner, A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708857 · Cited by 13,097
Management of Hepatocellular Carcinoma: An Update Δσ
Bruix, J., & Sherman, M. (2011) · Hepatology · doi:10.1002/hep.24199 · Cited by 8,103
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. Adults
Calle, E. E., Rodriguez, C., Walker-Thurmond, K., & Thun, M. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021423 · Cited by 7,696
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
Lampertico, P., Agarwal, K., Berg, T., Buti, M., Janssen, H. L. A., Papatheodoridis, G., Zoulim, F., & Tacke, F. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.03.021 · Cited by 5,391
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
Younossi, Z., Anstee, Q. M., Marietti, M., Hardy, T., Henry, L., Eslam, M., George, J., & Bugianesi, E. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.109 · Cited by 5,249
Bruix, J., Qin, S., Merle, P., Granito, A., Huang, Y.-H., Bodoky, G., Pracht, M., Yokosuka, O., Rosmorduc, O., Breder, V., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(16)32453-9 · Cited by 3,653
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
Sanyal, A. J., Chalasani, N., Kowdley, K. V., McCullough, A., Diehl, A. M., Bass, N. M., Neuschwander-Tetri, B. A., Lavine, J. E., Tonascia, J., Unalp, A., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907929 · Cited by 3,327
Risk of Hepatocellular Carcinoma Across a Biological Gradient of Serum Hepatitis B Virus DNA Level
Chen, C.-J. (2006) · JAMA · doi:10.1001/jama.295.1.65 · Cited by 3,140
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
Ghany, M. G., Strader, D. B., Thomas, D. L., & Seeff, L. B. (2009) · Hepatology · doi:10.1002/hep.22759 · Cited by 2,973
The global health burden of infection‐associated cancers in the year 2002
Parkin, D. M. (2006) · International Journal of Cancer · doi:10.1002/ijc.21731 · Cited by 2,932
HEPATOCELLULAR CARCINOMA AND HEPATITIS B VIRUS
Beasley, R. P., Lin, C.-C., Hwang, L.-Y., & Chien, C.-S. (1981) · The Lancet · doi:10.1016/s0140-6736(81)90585-7 · Cited by 2,865
Schweitzer, A., Horn, J., Mikolajczyk, R. T., Krause, G., & Ott, J. J. (2015) · The Lancet · doi:10.1016/s0140-6736(15)61412-x · Cited by 2,742
Hepatocellular carcinoma in cirrhosis: Incidence and risk factors
Fattovich, G., Stroffolini, T., Zagni, I., & Donato, F. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.014 · Cited by 2,591
Perz, J. F., Armstrong, G. L., Farrington, L. A., Hutin, Y. J. F., & Bell, B. P. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.05.013 · Cited by 2,572
Neuschwander-Tetri, B. A., Loomba, R., Sanyal, A. J., Lavine, J. E., Van Natta, M. L., Abdelmalek, M. F., Chalasani, N., Dasarathy, S., Diehl, A. M., Hameed, B., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61933-4 · Cited by 2,237
AASLD guidelines for treatment of chronic hepatitis B
Terrault, N. A., Bzowej, N. H., Chang, K., Hwang, J. P., Jonas, M. M., & Murad, M. H. (2016) · Hepatology · doi:10.1002/hep.28156 · Cited by 2,006
Self-citationMarcellin, P., Gane, E., Buti, M., Afdhal, N., Sievert, W., Jacobson, I. M., Washington, M. K., Germanidis, G., Flaherty, J. F., Schall, R. A., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(12)61425-1 · Cited by 1,788
GLOBOCAN 2008 v1.2, Cancer incidence and mortality world-wide : IARC Cancer Base No. 10
Ferlay, J. (2010) · Medical Entomology and Zoology · Cited by 1,633
Molecular pathogenesis of human hepatocellular carcinoma
Thorgeirsson, S. S., & Grisham, J. W. (2002) · Nature Genetics · doi:10.1038/ng0802-339 · Cited by 1,439
Panel, A. H. G. (2015) · Hepatology · doi:10.1002/hep.27950 · Cited by 1,382
Fattovich, G., Bortolotti, F., & Donato, F. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2007.11.011 · Cited by 1,348
Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis
Promrat, K., Kleiner, D. E., Niemeier, H. M., Jackvony, E., Kearns, M., Wands, J. R., Fava, J. L., & Wing, R. R. (2010) · Hepatology · doi:10.1002/hep.23276 · Cited by 1,330
Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma
El-serag, H. B., Tran, T., & Everhart, J. E. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.10.065 · Cited by 1,230
Definition of the Mediterranean Diet; A Literature Review
Davis, C., Bryan, J., Hodgson, J., & Murphy, K. (2015) · Nutrients · doi:10.3390/nu7115459 · Cited by 1,184
Poynard, T., McHutchison, J., Manns, M., Trepo, C., Lindsay, K., Goodman, Z., Ling, M., & Albrecht, J. (2002) · Gastroenterology · doi:10.1053/gast.2002.33023 · Cited by 1,146
Ratziu, V., Harrison, S. A., Francque, S., Bedossa, P., Lehert, P., Serfaty, L., Romero-Gomez, M., Boursier, J., Abdelmalek, M., Caldwell, S., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.01.038 · Cited by 1,035
Forner, A., Vilana, R., Ayuso, C., Bianchi, L., Solé, M., Ayuso, J. R., Boix, L., Sala, M., Varela, M., Llovet, J. M., et al. (2008) · Hepatology · doi:10.1002/hep.21966 · Cited by 1,032
Vertical Transmission of Hepatitis B Antigen in Taiwan
Stevens, C. E., Beasley, R. P., Tsui, J., & Lee, W.-C. (1975) · New England Journal of Medicine · doi:10.1056/nejm197504102921503 · Cited by 1,022
Reig, M., Mariño, Z., Perelló, C., Iñarrairaegui, M., Ribeiro, A., Lens, S., Díaz, A., Vilana, R., Darnell, A., Varela, M., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.04.008 · Cited by 1,018
Chang, T.-T., Liaw, Y.-F., Wu, S.-S., Schiff, E., Han, K.-H., Lai, C.-L., Safadi, R., Lee, S. S., Halota, W., Goodman, Z., et al. (2010) · Hepatology · doi:10.1002/hep.23785 · Cited by 972
Ryerson, A. B., Eheman, C. R., Altekruse, S. F., Ward, J. W., Jemal, A., Sherman, R. L., Henley, S. J., Holtzman, D., Lake, A., Noone, A., et al. (2016) · Cancer · doi:10.1002/cncr.29936 · Cited by 945
Risk of Hepatocellular Cancer in HCV Patients Treated With Direct-Acting Antiviral Agents
Kanwal, F., Kramer, J., Asch, S. M., Chayanupatkul, M., Cao, Y., & El-Serag, H. B. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.06.012 · Cited by 931
Conti, F., Buonfiglioli, F., Scuteri, A., Crespi, C., Bolondi, L., Caraceni, P., Foschi, F. G., Lenzi, M., Mazzella, G., Verucchi, G., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.06.015 · Cited by 897
Morgan, R. L., Baack, B., Smith, B. D., Yartel, A., Pitasi, M., & Falck-Ytter, Y. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-158-5-201303050-00005 · Cited by 829
Wu, C.-Y., Chen, Y.-J., Ho, H. J., Hsu, Y.-C., Kuo, K. N., Wu, M.-S., & Lin, J.-T. (2012) · JAMA · doi:10.1001/2012.jama.11975 · Cited by 818
White, D. L., Kanwal, F., & El–Serag, H. B. (2012) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.10.001 · Cited by 766
Non-alcoholic fatty liver disease: An expanded review
Benedict, M., & Zhang, X. (2017) · World Journal of Hepatology · doi:10.4254/wjh.v9.i16.715 · Cited by 751
The Epidemiology of Nonalcoholic Fatty Liver Disease: A Global Perspective
Lazo, M., & Clark, J. (2008) · Seminars in Liver Disease · doi:10.1055/s-0028-1091978 · Cited by 736
Denniston, M. M., Jiles, R. B., Drobeniuc, J., Klevens, R. M., Ward, J. W., McQuillan, G. M., & Holmberg, S. D. (2014) · Annals of Internal Medicine · doi:10.7326/m13-1133 · Cited by 724
Review of hepatocellular carcinoma: Epidemiology, etiology, and carcinogenesis
Rowe, J., Ghouri, Y., & Mian, I. (2017) · Journal of Carcinogenesis · doi:10.4103/jcar.jcar_9_16 · Cited by 719
Hosaka, T., Suzuki, F., Kobayashi, M., Seko, Y., Kawamura, Y., Sezaki, H., Akuta, N., Suzuki, Y., Saitoh, S., Arase, Y., et al. (2013) · Hepatology · doi:10.1002/hep.26180 · Cited by 710
Davila, J. A., Morgan, R. O., Shaib, Y., McGlynn, K. A., & El-Serag, H. B. (2005) · Gut · doi:10.1136/gut.2004.052167 · Cited by 704
Marrero, J. A., Fontana, R. J., Su, G. L., Conjeevaram, H. S., Emick, D. M., & Lok, A. S. (2002) · Hepatology · doi:10.1002/hep.1840360609 · Cited by 660
Decreased Incidence of Hepatocellular Carcinoma in Hepatitis B Vaccinees: A 20-Year Follow-up Study
Chang, M.-H., You, S.-L., Chen, C.-J., Liu, C.-J., Lee, C.-M., Lin, S.-M., Chu, H.-C., Wu, T.-C., Yang, S.-S., Kuo, H.-S., et al. (2009) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djp288 · Cited by 635
Hepatology. A Textbook of Liver Disease
(1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-113-3-259_2 · Cited by 621
THE e ANTIGEN AND VERTICAL TRANSMISSION OF HEPATITIS B SURFACE ANTIGEN
BEASLEY, R. P., TREPO, C., STEVENS, C. E., & SZMUNESS, W. (1977) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112370 · Cited by 611
Vilar-Gomez, E., & Chalasani, N. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2017.11.013 · Cited by 610
A prospective study of obesity and cancer risk (Sweden)
Wolk, A., Gridley, G., Svensson, M., Nyrén, O., McLaughlin, J. K., Fraumeni, J. F., & Adami, H.-O. (2001) · Cancer Causes & Control · doi:10.1023/a:1008995217664 · Cited by 581
Tenofovir to Prevent Hepatitis B Transmission in Mothers with High Viral Load
Pan, C. Q., Duan, Z., Dai, E., Zhang, S., Han, G., Wang, Y., Zhang, H., Zou, H., Zhu, B., Zhao, W., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1508660 · Cited by 573
Paradis, V., Zalinski, S., Chelbi, E., Guedj, N., Degos, F., Vilgrain, V., Bedossa, P., & Belghiti, J. (2009) · Hepatology · doi:10.1002/hep.22734 · Cited by 571
Chen, C., Yang, H., Yang, W., Liu, C., Chen, P., You, S., Wang, L., Sun, C., Lu, S., Chen, D., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.073 · Cited by 549
Welzel, T. M., Graubard, B. I., Zeuzem, S., El-Serag, H. B., Davila, J. A., & McGlynn, K. A. (2011) · Hepatology · doi:10.1002/hep.24397 · Cited by 543
Donato, F., Boffetta, P., & Puoti, M. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980130)75:3<347::aid-ijc4>3.0.co;2-2 · Cited by 543
Papatheodoridis, G. V., Chan, H. L.-Y., Hansen, B. E., Janssen, H. L. A., & Lampertico, P. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.01.002 · Cited by 511
World‐wide relative contribution of hepatitis B and C viruses in hepatocellular carcinoma
de Martel, C., Maucort‐Boulch, D., Plummer, M., & Franceschi, S. (2015) · Hepatology · doi:10.1002/hep.27969 · Cited by 503
Waziry, R., Hajarizadeh, B., Grebely, J., Amin, J., Law, M., Danta, M., George, J., & Dore, G. J. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.07.025 · Cited by 500
Wong, V. W., Reesink, H., Ip, H. H., Nco Lelie, P., Reerink-Brongers, E., Yeung, C. Y., & Ma, H. K. (1984) · The Lancet · doi:10.1016/s0140-6736(84)92388-2 · Cited by 480
The Global Epidemiology of Hepatocellular Carcinoma: Present and Future
McGlynn, K. A., & London, W. T. (2011) · Clinics in Liver Disease · doi:10.1016/j.cld.2011.03.006 · Cited by 471
Lyman, G. H., Dale, D. C., & Crawford, J. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.05.002 · Cited by 464
Singh, S., Singh, P. P., Singh, A. G., Murad, M. H., & Sanchez, W. (2013) · Gastroenterology · doi:10.1053/j.gastro.2012.10.005 · Cited by 452
Obesity and cancer risk: a danish record-linkage study
Møller, H., Mellemgaard, A., Lindvig, K., & Olsen, J. H. (1994) · European Journal of Cancer · doi:10.1016/0959-8049(94)90254-2 · Cited by 448
Lok, A. S. F. (2002) · New England Journal of Medicine · doi:10.1056/nejm200205303462202 · Cited by 442
Future of Hepatocellular Carcinoma Incidence in the United States Forecast Through 2030
Petrick, J. L., Kelly, S. P., Altekruse, S. F., McGlynn, K. A., & Rosenberg, P. S. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.64.7412 · Cited by 442
Toward a more accurate estimate of the prevalence of hepatitis C in the United States
Edlin, B. R., Eckhardt, B. J., Shu, M. A., Holmberg, S. D., & Swan, T. (2015) · Hepatology · doi:10.1002/hep.27978 · Cited by 433
Cowey, S., & Hardy, R. W. (2006) · The American Journal of Pathology · doi:10.2353/ajpath.2006.051090 · Cited by 431
Hepatocellular carcinoma in the Asia pacific region
Yuen, M., Hou, J., & Chutaputti, A. (2009) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2009.05784.x · Cited by 427
Self-citationLee, C., Gong, Y., Brok, J., Boxall, E. H., & Gluud, C. (2006) · BMJ · doi:10.1136/bmj.38719.435833.7c · Cited by 402
Statin use and non-alcoholic steatohepatitis in at risk individuals
Dongiovanni, P., Petta, S., Mannisto, V., Mancina, R. M., Pipitone, R., Karja, V., Maggioni, M., Kakela, P., Wiklund, O., Mozzi, E., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.05.006 · Cited by 390
Relation of body mass index to cancer risk in 362,552 Swedish men
Samanic, C., Chow, W.-H., Gridley, G., Jarvholm, B., & Fraumeni, J. F. (2006) · Cancer Causes & Control · doi:10.1007/s10552-006-0023-9 · Cited by 381
Prognostic determinants for chronic hepatitis B in Asians: therapeutic implications
Yuen, M.-F., Yuan, H.-J., Wong, D. K.-H., Yuen, J. C.-H., Wong, W.-M., Chan, A. O.-O., Wong, B. C.-Y., Lai, K.-C., & Lai, C.-L. (2005) · Gut · doi:10.1136/gut.2005.065136 · Cited by 375
Self-citationMeta‐analysis: treatment of hepatitis B infection reduces risk of hepatocellular carcinoma
SUNG, J. J. Y., TSOI, K. K. F., WONG, V. W. S., LI, K. C. T., & CHAN, H. L. Y. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2008.03816.x · Cited by 370
Zou, H., Chen, Y., Duan, Z., Zhang, H., & Pan, C. (2012) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2011.01492.x · Cited by 366
Verslype, C., Rosmorduc, O., & Rougier, P. (2012) · Annals of Oncology · doi:10.1093/annonc/mds225 · Cited by 365
Singal, A. G., Manjunath, H., Yopp, A. C., Beg, M. S., Marrero, J. A., Gopal, P., & Waljee, A. K. (2014) · American Journal of Gastroenterology · doi:10.1038/ajg.2013.476 · Cited by 362
Rising mortality associated with hepatitis C virus in the United States, 2003–2013
Ly, K. N., Hughes, E. M., Jiles, R. B., & Holmberg, S. D. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw111 · Cited by 358
Zhang, H., Zhai, Y., Hu, Z., Wu, C., Qian, J., Jia, W., Ma, F., Huang, W., Yu, L., Yue, W., et al. (2010) · Nature Genetics · doi:10.1038/ng.638 · Cited by 346
Association of Obesity and Cancer Risk in Canada
Pan, S. Y. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh041 · Cited by 339
Staging systems in hepatocellular carcinoma
Pons, F., Varela, M., & Llovet, J. M. (2005) · HPB · doi:10.1080/13651820410024058 · Cited by 334
Obesity and incidence of cancer: a large cohort study of over 145 000 adults in Austria
Rapp, K., Schroeder, J., Klenk, J., Stoehr, S., Ulmer, H., Concin, H., Diem, G., Oberaigner, W., & Weiland, S. K. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602819 · Cited by 332
Metabolic syndrome and nonalcoholic fatty liver disease: Is insulin resistance the link?
Asrih, M., & Jornayvaz, F. R. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.02.018 · Cited by 330
Population-Attributable Fractions of Risk Factors for Hepatocellular Carcinoma in the United States
Welzel, T. M., Graubard, B. I., Quraishi, S., Zeuzem, S., Davila, J. A., El-Serag, H. B., & McGlynn, K. A. (2013) · American Journal of Gastroenterology · doi:10.1038/ajg.2013.160 · Cited by 328
Brown, R. S., McMahon, B. J., Lok, A. S. F., Wong, J. B., Ahmed, A. T., Mouchli, M. A., Wang, Z., Prokop, L. J., Murad, M. H., & Mohammed, K. (2016) · Hepatology · doi:10.1002/hep.28302 · Cited by 324
Obesity and cancer risk among white and black United States veterans
Samanic, C., Gridley, G., Chow, W.-H., Lubin, J., Hoover, R. N., & Fraumeni, J. F. (2004) · Cancer Causes & Control · doi:10.1023/b:caco.0000016573.79453.ba · Cited by 318
Diabetes mellitus and risk of hepatocellular carcinoma: a systematic review and meta‐analysis
Wang, P., Kang, D., Cao, W., Wang, Y., & Liu, Z. (2012) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1291 · Cited by 310
Brunello, F., Veltri, A., Carucci, P., Pagano, E., Ciccone, G., Moretto, P., Sacchetto, P., Gandini, G., & Rizzetto, M. (2008) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520701885481 · Cited by 302
Papatheodoridis, G. V., Idilman, R., Dalekos, G. N., Buti, M., Chi, H., van Boemmel, F., Calleja, J. L., Sypsa, V., Goulis, J., Manolakopoulos, S., et al. (2017) · Hepatology · doi:10.1002/hep.29320 · Cited by 301
Changing trends in malignant transformation of hepatocellular adenoma
Farges, O., Ferreira, N., Dokmak, S., Belghiti, J., Bedossa, P., & Paradis, V. (2011) · Gut · doi:10.1136/gut.2010.222109 · Cited by 299
Trépo, E., Romeo, S., Zucman-Rossi, J., & Nahon, P. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.03.011 · Cited by 291
Cirrhosis Is Present in Most Patients With Hepatitis B and Hepatocellular Carcinoma
Yang, J. D., Kim, W. R., Coelho, R., Mettler, T. A., Benson, J. T., Sanderson, S. O., Therneau, T. M., Kim, B., & Roberts, L. R. (2011) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2010.08.019 · Cited by 266
Yuen, M.-F., Seto, W.-K., Chow, D. H.-F., Tsui, K., Wong, D. K.-H., Ngai, V. W.-S., Wong, B. C.-Y., Fung, J., Yuen, J. C.-H., & Lai, C.-L. (2007) · Antiviral Therapy · doi:10.1177/135965350701200816 · Cited by 257
Self-citationA Serologic Follow-up of the 1942 Epidemic of Post-Vaccination Hepatitis in the United States Army
Seeff, L. B., Beebe, G. W., Hoofnagle, J. H., Norman, J. E., Buskell-Bales, Z., Waggoner, J. G., Kaplowitz, N., Koff, R. S., Petrini, J. L., Schiff, E. R., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198704163161601 · Cited by 254
The story of HCC in NAFLD: from epidemiology, across pathogenesis, to prevention and treatment
Margini, C., & Dufour, J. F. (2016) · Liver International · doi:10.1111/liv.13031 · Cited by 246
Guide for diagnosis and treatment of hepatocellular carcinoma
Attwa, M. H. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i12.1632 · Cited by 242
Zhang, Z.-J., Zheng, Z.-J., Shi, R., Su, Q., Jiang, Q., & Kip, K. E. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1267 · Cited by 241
Shi, J., Zhu, L., Liu, S., & Xie, W.-F. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602333 · Cited by 215
Hsu, Y.-C., Ho, H. J., Huang, Y.-T., Wang, H.-H., Wu, M.-S., Lin, J.-T., & Wu, C.-Y. (2015) · Gut · doi:10.1136/gutjnl-2014-308163 · Cited by 214
Obesity and risk of cancer in Japan
Kuriyama, S., Tsubono, Y., Hozawa, A., Shimazu, T., Suzuki, Y., Koizumi, Y., Suzuki, Y., Ohmori, K., Nishino, Y., & Tsuji, I. (2005) · International Journal of Cancer · doi:10.1002/ijc.20529 · Cited by 213
Guzman, G., Brunt, E. M., Petrovic, L. M., Chejfec, G., Layden, T. J., & Cotler, S. J. (2008) · Archives of Pathology & Laboratory Medicine · doi:10.5858/132.11.1761 · Cited by 212
Kim, W. R., Loomba, R., Berg, T., Aguilar Schall, R. E., Yee, L. J., Dinh, P. V., Flaherty, J. F., Martins, E. B., Therneau, T. M., Jacobson, I., et al. (2015) · Cancer · doi:10.1002/cncr.29537 · Cited by 212
The impact of obesity and diabetes mellitus on the risk of hepatocellular carcinoma
Polesel, J., Zucchetto, A., Montella, M., Dal Maso, L., Crispo, A., La Vecchia, C., Serraino, D., Franceschi, S., & Talamini, R. (2009) · Annals of Oncology · doi:10.1093/annonc/mdn565 · Cited by 210
Prevention of hepatitis B virus–related hepatocellular carcinoma with antiviral therapy
Lai, C.-L., & Yuen, M.-F. (2013) · Hepatology · doi:10.1002/hep.25937 · Cited by 208
Self-citationHepatocellular carcinoma arising from non-cirrhotic nonalcoholic steatohepatitis
Kawada, N., Imanaka, K., Kawaguchi, T., Tamai, C., Ishihara, R., Matsunaga, T., Gotoh, K., Yamada, T., & Tomita, Y. (2009) · Journal of Gastroenterology · doi:10.1007/s00535-009-0112-0 · Cited by 204
Chan, A. W. H., Wong, G. L. H., Chan, H., Tong, J. H. M., Yu, Y., Choi, P. C. L., Chan, H. L. Y., To, K., & Wong, V. W. S. (2017) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.13536 · Cited by 200
Body mass index and cancer risk in Korean men and women
Jee, S. H., Yun, J. E., Park, E. J., Cho, E. R., Park, I. S., Sull, J. W., Ohrr, H., & Samet, J. M. (2008) · International Journal of Cancer · doi:10.1002/ijc.23719 · Cited by 199
MATSUMOTO, A., TANAKA, E., ROKUHARA, A., KIYOSAWA, K., KUMADA, H., OMATA, M., OKITA, K., HAYASHI, N., OKANOUE, T., & IINO, S. (2005) · Hepatology Research · doi:10.1016/j.hepres.2005.02.006 · Cited by 194
Cholankeril, G., Patel, R., Khurana, S., & Satapathy, S. K. (2017) · World Journal of Hepatology · doi:10.4254/wjh.v9.i11.533 · Cited by 183
Hepatocellular carcinoma. An overview
Motola-Kuba, D., Zamora-Valdés, D., Uribe, M., & Méndez-Sánchez, N. (2006) · Annals of Hepatology · doi:10.1016/s1665-2681(19)32034-4 · Cited by 181
Self-citationAFP-Producing Gastric Carcinoma: Multivariate Analysis of Prognostic Factors in 270 Patients
Adachi, Y., Tsuchihashi, J., Shiraishi, N., Yasuda, K., Etoh, T., & Kitano, S. (2003) · Oncology · doi:10.1159/000072332 · Cited by 180
Knop, V., Hoppe, D., Welzel, T. M., Vermehren, J., Herrmann, E. M., Vermehren, A., Friedrich-Rust, M., Sarrazin, C., Zeuzem, S., & Welker, M. ‐. (2016) · Journal of Viral Hepatitis · doi:10.1111/jvh.12578 · Cited by 180
Yuen, M.-F., Tanaka, Y., Shinkai, N., Poon, R. T. P., But, D. Y.-K., Fong, D., Fung, J., Wong, D. K.-H., Yuen, J. C., Mizokami, M., et al. (2007) · Gut · doi:10.1136/gut.2007.119859 · Cited by 178
Self-citationMetabolic risk factors and primary liver cancer in a prospective study of 578,700 adults
Borena, W., Strohmaier, S., Lukanova, A., Bjørge, T., Lindkvist, B., Hallmans, G., Edlinger, M., Stocks, T., Nagel, G., Manjer, J., et al. (2012) · International Journal of Cancer · doi:10.1002/ijc.26338 · Cited by 177
Yu, M.-W., Lin, C.-L., Liu, C.-J., Yang, S.-H., Tseng, Y.-L., & Wu, C.-F. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.07.001 · Cited by 176
Hepatocellular carcinoma: From diagnosis to treatment
Waghray, A. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i8.1020 · Cited by 174
Laboratory Diagnostics for Hepatitis C Virus Infection
Kamili, S., Drobeniuc, J., Araujo, A. C., & Hayden, T. M. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis368 · Cited by 173
Distinctive features of hepatocellular carcinoma in non-alcoholic fatty liver disease
Degasperi, E., & Colombo, M. (2016) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(16)30018-8 · Cited by 171
Cabibbo, G., Petta, S., Calvaruso, V., Cacciola, I., Cannavò, M. R., Madonia, S., Distefano, M., Larocca, L., Prestileo, T., Tinè, F., et al. (2017) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14256 · Cited by 161
Mediterranean diet and hepatocellular carcinoma
Turati, F., Trichopoulos, D., Polesel, J., Bravi, F., Rossi, M., Talamini, R., Franceschi, S., Montella, M., Trichopoulou, A. D., Vecchia, C. L., et al. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.10.034 · Cited by 157
Mallet, V. O., van Bömmel, F., Doerig, C., Pischke, S., Hermine, O., Locasciulli, A., Cordonnier, C., Berg, T., Moradpour, D., Wedemeyer, H. H., et al. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)00118-3 · Cited by 155
Schlesinger, S., Aleksandrova, K., Pischon, T., Jenab, M., Fedirko, V., Trépo, E., Overvad, K., Roswall, N., Tjønneland, A. M., Boutron‐Ruault, M., et al. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt204 · Cited by 149
Xu, R., Tao, A., Zhang, S., Deng, Y., & Chen, G. (2015) · Scientific Reports · doi:10.1038/srep09284 · Cited by 147
Mahale, P. S., Engels, E. A., Li, R., Torres, H. A., Hwang, L., Brown, E. L., & Kramer, J. R. (2017) · Gut · doi:10.1136/gutjnl-2017-313983 · Cited by 141
Self-citationErhardt, A., Stahl, W., Sies, H., Lirussi, F., Donner, A., & Häussinger, D. (2011) · European Journal of Medical Research · doi:10.1186/2047-783x-16-2-76 · Cited by 140
Batty, G. D., Shipley, M. J., Jarrett, R. J., Breeze, E., Marmot, M. G., & Smith, G. D. (2005) · International Journal of Obesity · doi:10.1038/sj.ijo.0803020 · Cited by 139
Hepatocellular carcinoma and lifestyles
Saran, U., Humar, B., Kolly, P., & Dufour, J. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.08.028 · Cited by 134
Jinjuvadia, R., Patel, S., & Liangpunsakul, S. (2014) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e3182a030c4 · Cited by 132
Molecular Pathogenesis of Hepatocellular Carcinoma
Ho, D. W., Lo, R. C., Chan, L., & Ng, I. O. (2016) · Liver Cancer · doi:10.1159/000449340 · Cited by 132
Piguet, A., Saran, U., Simillion, C., Keller, I., Terracciano, L., Reeves, H. L., & Dufour, J. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.01.017 · Cited by 128
Viral Elimination Reduces Incidence of Malignant Lymphoma in Patients with Hepatitis C
Kawamura, Y., Ikeda, K., Arase, Y., Yatsuji, H., Sezaki, H., Hosaka, T., Akuta, N., Kobayashi, M., Suzuki, F., Suzuki, Y., et al. (2007) · The American Journal of Medicine · doi:10.1016/j.amjmed.2007.06.022 · Cited by 127
Fung, J., Wong, T. C.-L., Chok, K., Chan, A. C. Y., Cheung, T. T., Dai, J. W.-C., Sin, S., Ma, K., Ng, K. K., Ng, T., et al. (2017) · Hepatology · doi:10.1002/hep.29191 · Cited by 126
Self-citationMolecular Pathogenesis of Hepatocellular Carcinoma
McKillop, I. H., Moran, D. M., Jin, X., & Koniaris, L. G. (2006) · Journal of Surgical Research · doi:10.1016/j.jss.2006.04.013 · Cited by 115
Fedirko, V., Duarte‐Salles, T., Bamia, C., Trichopoulou, A. D., Aleksandrova, K., Trichopoulos, D., Trépo, E., Tjønneland, A. M., Olsen, A., Overvad, K., et al. (2014) · Hepatology · doi:10.1002/hep.27079 · Cited by 113
The oncologic burden of hepatitis C virus infection: A clinical perspective
Torres, H. A., Shigle, T. L., Hammoudi, N., Link, J. T., Samaniego, F., Kaseb, A. O., & Mallet, V. O. (2017) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21403 · Cited by 113
Self-citationPerumpail, R. B., Wong, R. J., Ahmed, A., & Harrison, S. A. (2015) · Digestive Diseases and Sciences · doi:10.1007/s10620-015-3821-7 · Cited by 111
SAUNDERS, D., SEIDEL, D., ALLISON, M., & LYRATZOPOULOS, G. (2010) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2010.04271.x · Cited by 111
Risk Factors for Hepatocellular Carcinoma in a Japanese Population: A Nested Case-Control Study
Ohishi, W., Fujiwara, S., Cologne, J. B., Suzuki, G., Akahoshi, M., Nishi, N., Takahashi, I., & Chayama, K. (2008) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-2806 · Cited by 106
Varbobitis, I. C., & Papatheodoridis, G. (2016) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2016.0045 · Cited by 100
Campbell, C., Canary, L., Smith, N., Teshale, E. H., Ryerson, A. B., & Ward, J. W. (2017) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6618a2 · Cited by 96
Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma
Massoud, O. I., & Charlton, M. (2017) · Clinics in Liver Disease · doi:10.1016/j.cld.2017.08.014 · Cited by 94
Lee, T., Lin, J., Zeng, Y., Chen, Y., Wu, M., & Wu, C. (2015) · Hepatology · doi:10.1002/hep.28266 · Cited by 83
Torres, H. A., Vauthey, J., Economides, M. P., Mahale, P. S., & Kaseb, A. O. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.05.034 · Cited by 81
Self-citationIdentification of Drivers from Cancer Genome Diversity in Hepatocellular Carcinoma
Takai, A., Dang, H. T., & Wang, X. W. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms150611142 · Cited by 77
Radioembolization with Yttrium-90 microspheres in hepatocellular carcinoma: Role and perspectives
Mosconi, C., Cappelli, A., Pettinato, C., & Golfieri, R. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i5.738 · Cited by 75
Zampino, R., Pisaturo, M., Cirillo, G., Marrone, A., Macera, M., Rinaldi, L., Stanzione, M., Durante‐Mangoni, E., Gentile, I., Sagnelli, E., et al. (2015) · Annals of Hepatology · doi:10.1016/s1665-2681(19)30803-8 · Cited by 71
Machaira, M., Papaevangelou, V., Vouloumanou, E. K., Tansarli, G. S., & Falagas, M. E. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku404 · Cited by 70
Role of the multidisciplinary team in the diagnosis and treatment of hepatocellular carcinoma
Gish, R. G., Lencioni, R. A., Bisceglie, A. M. D., Raoul, J., & Mazzaferro, V. (2012) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/egh.11.105 · Cited by 70
Advances in hepatocellular carcinoma: Nonalcoholic steatohepatitis-related hepatocellular carcinoma
Khan, F. Z. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i18.2155 · Cited by 66
The Epidemiology, Natural History and Prevention of Hepatitis B: Implications of HIV Coinfection
McGovern, B. (2007) · Antiviral Therapy · doi:10.1177/135965350701203s02 · Cited by 65
Coffin, C. S., Rezaeeaval, M., Pang, J. X. Q., Alcantara, L., Klein, P. L., Burak, K. W., & Myers, R. P. (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12990 · Cited by 65
Torres, H. A., Chong, P. P., Lima, M. J. G. D., Friedman, M., Giralt, S. A., Hammond, S. P., Kiel, P. J., Masur, H., McDonald, G. B., Wingard, J. R., et al. (2015) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2015.07.033 · Cited by 59
Self-citationArslanoğlu, A., Seyal, A. R., Sodagari, F., Sahin, A., Miller, F. H., Salem, R., & Yaghmai, V. (2016) · American Journal of Roentgenology · doi:10.2214/ajr.15.15490 · Cited by 58
Tissue Diagnosis of Hepatocellular Carcinoma
Jain, D. (2014) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2014.03.047 · Cited by 55
Chinchilla-López, P., Ramírez-Pérez, O., Cruz-Ramón, V., Canizales‐Quinteros, S., Domínguez‐López, A., Ponciano‐Rodríguez, G., Sánchez‐Muñoz, F., & Méndez‐Sánchez, N. (2018) · Annals of Hepatology · doi:10.5604/01.3001.0010.8644 · Cited by 54
Self-citationSubcutaneous vitamin E ameliorates liver injury in an in vivo model of steatocholestasis†‡
Soden, J. S., Devereaux, M. W., Haas, J. E., Gumpricht, E., Dahl, R., Gralla, J., Traber, M. G., & Sokol, R. J. (2007) · Hepatology · doi:10.1002/hep.21690 · Cited by 53
Prevention of hepatocellular carcinoma in chronic viral hepatitis B and C infection
Lu, T. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i47.8887 · Cited by 45
Smith, B. D., Yartel, A. K., Krauskopf, K., Massoud, O. I., Brown, K., Fallon, M. B., & Rein, D. B. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ002 · Cited by 35
Obesity as a cause of hepatocellular carcinoma
Kew, M. C. (2015) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31267-0 · Cited by 33
Cited by
Ohtani, N., & Kawada, N. (2019) · Hepatology Communications · doi:10.1002/hep4.1331 · Cited by 187
“(77,78) On the other hand, the incidence of NASH, the aggressive inflammatory form of nonalcoholic fatty liver disease (NAFLD) without viral etiology, and NASH-associated cirrhosis and HCC is rapidly increasing.(78-81) Moreover, molecular-based therapies for NASH have been developed, and these therapies could also hel…”
BackgroundCritical role of estrogen in the progression of chronic liver diseases
Ezhilarasan, D. (2020) · Hepatobiliary & Pancreatic Diseases International · doi:10.1016/j.hbpd.2020.03.011 · Cited by 96
Flavonoids: A Myth or a Reality for Cancer Therapy?
Forni, C., Rossi, M., Borromeo, I., Feriotto, G., Platamone, G., Tabolacci, C., Mischiati, C., & Beninati, S. (2021) · Molecules · doi:10.3390/molecules26123583 · Cited by 79
Liao, H., Xiong, T., Peng, J., Xu, L., Liao, M., Zhang, Z., Wu, Z., Yuan, K., & Zeng, Y. (2020) · Annals of Surgical Oncology · doi:10.1245/s10434-019-08190-1 · Cited by 65
Mak, L.-Y., Hui, R. W.-H., Fung, J., Liu, F., Wong, D. K.-H., Li, B., Cheung, K.-S., Yuen, M.-F., & Seto, W.-K. (2021) · Hepatology International · doi:10.1007/s12072-021-10218-2 · Cited by 58
Self-citation
Metadata
- Authors
- Mak, L.-Y., Cruz-Ramón, V., Chinchilla-López, P., Torres, H. A., LoConte, N. K., Rice, J. P., Foxhall, L. E., Sturgis, E. M., Merrill, J. K., Bailey, H. H., Méndez-Sánchez, N., Yuen, M.-F., & Hwang, J. P.
- Venue
- American Society of Clinical Oncology Educational Book
- Published
- 2018-05
- Volume
- 38
- Issue
- 38
- Pages
- 262-279
- ISSN
- 1548-8748 (ISSN-L)
- 1548-8756
- OpenAlex
- W2806541405
- Cited by
- 237
- References
- 159
- FWCI
- 13.87
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.